Lobbying Filing Details

Total Spending

$340,000

Activities

4

Lobbyists

3

Gov't Entities

8

Filing Information
Filing UUID:
a39d404c-0454-41da-9eae-2067ca6c79ee
Type:
2A - 2nd Quarter - Amendment
Period:
2026 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
July 20, 2026 at 9:06 PM
Income:
$0
Expenses:
$340,000
Expense Method:
A
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Jason D. Kaune, Attorney & Agent for Filer
Registrant
BIOMARIN PHARMACEUTICAL INC.

Develops and commercializes biopharmaceuticals.

San Rafael, California
Client
BIOMARIN PHARMACEUTICAL INC.
California, United States of America
Lobbying Activities (4)
Activity 1
Health Issues

GENERAL DISCUSSIONS REGARDING MEDICAID GENERAL DISCUSSIONS REGARDING NEWBORN SCREENING GENERAL DISCUSSIONS REGARDING ORPHAN DRUGS GENERAL DISCUSSIONS REGARDING PATIENT EXPERIENCE DATA GENERAL DISCUSSIONS REGARDING RECOMMENDED UNIFORM SCREENING PANEL (RUSP) CONDITION ADDITION GENERAL DISCUSSIONS REGARDING GENETIC SCREENING AND TESTING

Lobbyists (3)
  • KATHRYN LOWELL
  • JOHN EDWARD GREISSING
  • DANIEL MAYNE
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Health & Human Services, Dept of (HHS)
  • Health Resources & Services Administration (HRSA)
Activity 2
Medical/Disease Research/Clinical Labs

GENERAL DISCUSSIONS REGARDING CLINICAL TRIAL MODERNIZATION

Lobbyists (1)
  • DANIEL MAYNE
Government Entities (1)
  • HOUSE OF REPRESENTATIVES
Activity 3
Medicare/Medicaid

GENERAL DISCUSSIONS RELATED TO MOST-FAVORED-NATION (MFN) FOREIGN REFERENCE PRICING GENERAL DISCUSSIONS REGARDING MEDICAID PRIOR AUTHORIZATION GENERAL DISCUSSIONS REGARDING UTILIZATION MANAGEMENT

Lobbyists (3)
  • KATHRYN LOWELL
  • JOHN EDWARD GREISSING
  • DANIEL MAYNE
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 4
Tariff (miscellaneous tariff bills)

GENERAL DISCUSSIONS REGARDING TARDE

Lobbyists (1)
  • KATHRYN LOWELL
Government Entities (1)
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 9, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.